" class="no-js "lang="en-US"> Cardinal Santos Medical Center - Medtech Alert
Friday, August 08, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Cardinal Santos Medical Center | Pharmtech Focus

Cardinal Santos Medical Center

About Cardinal Santos Medical Center

Cardinal Santos Medical Center
Cardinal Santos Medical Center is one of the Philippines’ leading hospitals specializing in the fields of Cardiology, Neurosurgery, Oncology, and Rehabilitation Medicine. It is also known for its expertise in Pediatrics, Obstetrics and Gynecology, Pulmonary Medicine, Gastroenterology/Diagnostic and Advanced Therapeutic Endoscopy, Nephrology, Urology, and Minimally Invasive Surgery.

Related Story

Diseases

 New Early Breast Cancer Drug to Reduce Risk of Recurrence or Death Now Available in the Philippines | Pharmtech Focus

New Early Breast Cancer Drug to Reduce Risk of Recurrence or Death Now Available in the Philippines

July 11 2022

A NEW drug shown to significantly reduce the risk of cancer recurrence or death in […]